Delisting Boston Scientific Synergy Drug Eluting Stent Products Notice of Alternative (ICN 2369)

• The discontinuation of Synergy Drug Eluting Stent products from Boston Scientific has now been resolved.
• All Synergy II product codes are being delisted on 22 April 2024.
• This ICN is now closed.

• The discontinuation of Synergy Drug Eluting Stent products from Boston Scientific is continuing.
• The Synergy II range will be delisted and unavailable to order from our online catalogue on 28 March 2024.
• There are 65 product codes affected.
• The direct alternative product codes have been updated on the product listing.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and alternatives.
• The new range is now available to order from our online catalogue.

Change:

• The supplier Boston Scientific has informed us of a discontinuation with its Synergy Drug Eluting Stent products.
• There are 65 product codes affected.
• The supplier is discontinuing these products due to the manufacture of a new range of stent products to replace the current Synergy II.

Impact:          

• The affected product codes are available whilst stocks last and will then be delisted from our online catalogue.
• Potential direct alternative products are available to order through our online catalogue.
• See our Downloads ▼ section to access the product listing below for further information on the affected product codes and potential alternatives.

Next Steps:              

• Customers are advised to log into our website to view the potential direct alternative products.
• Please note that due to the clinical nature of these alternative products we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.